Medplus Health Services Ltd

NSE: MEDPLUS · BSE: 543427 · Healthcare · 22 announcements

Share price: ₹654.90
Market cap: ₹7,868 Cr
Revenue (annual): ₹6,892 Cr
Net profit (annual): ₹219.7 Cr
P/E (TTM): 37.4×Sector 57.8×
Promoter holding: 40.19%-0.03% QoQ
FII holding: 14.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

25 Sep 2026 19:09 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.

Value: ₹0.01 Cr
From: Drugs Control Administration, Haveri Circle, Karnataka

Read the filing ↗

22 Sep 2026 18:02 IST BSE

Legal & Regulatory

Medplus Health Services Legal & Regulatory

MedPlus Health Services' subsidiary, Optival Health Solutions, received a one-day drug license suspension from the Drugs Control Administration for a store in Telangana due to non-compliance.

Value: ₹0.01 Cr

Read the filing ↗

21 Sep 2026 18:29 IST BSE

Legal & Regulatory

Medplus Health Services Legal & Regulatory

Medplus Health Services' subsidiary, Optival Health, received a 7-day drug license suspension in Andhra Pradesh and stay orders for previous suspensions in Maharashtra.

Value: ₹0.02 Cr

Read the filing ↗